A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.

Medtronic (MDT) lost ~5% in the premarket on Tuesday after the MedTech giant released its Q3 results for fiscal 2026, reaffirming its full-year earnings outlook that was in line with Street forecasts ...

The bull case for any stock often rests on several aspects of the business. That certainly applies to Medtronic (NYSE: MDT), a healthcare leader. Bulls could point to many reasons the stock is worth ...

Medtronic MDT-0.91%decrease; red down pointing triangle said profit fell in its fiscal third quarter as costs rose and the company invested more money into the business, offsetting higher revenue. The ...

Medtronic PLC (NYSE: MDT) posted better-than-expected earnings for the third quarter on Tuesday. The company posted adjusted EPS of $1.36, beating market estimates of $1.33. The company’s quarterly ...

The data in this schedule has been intentionally rounded to the nearest million, and, therefore, may not sum. View original content to download multimedia:https://www ...

TUCSON, Ariz. (KOLD/Gray News) - As the search for 84-year-old Nancy Guthrie enters its third week, the FBI is employing new technology that could help locate her using signals from her pacemaker. Law ...

The search for Nancy Guthrie has taken a high-tech turn. The Arizona police department is now flying over the Tucson, Ariz., desert with a Bluetooth signal detector, also known as a signal sniffer, in ...

Add Yahoo as a preferred source to see more of our stories on Google. The search for Nancy Guthrie is in its eighth day, and investigators are still working around the clock to find her—and to find ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X According to a Saturday, February 14, report from Fox News Digital, law enforcement officials ...

Medtronic plc (NYSE:MDT) is included among the 13 Cheapest Dividend Aristocrats to Invest in. On February 9, Needham & Company upgraded Medtronic plc (NYSE:MDT) to Buy from Hold. It set a $121 price ...